News | Treatment Planning | September 12, 2022

RaySearch Laboratories AB (publ) announces that Sunnybrook Health Sciences Centre – Odette Cancer Centre in Toronto, Canada, has placed an order for RayStation treatment planning system

RaySearch Laboratories AB (publ) announces that Sunnybrook Health Sciences Centre – Odette Cancer Centre in Toronto, Canada, has placed an order for RayStation treatment planning system.

September 12, 2022 — Sunnybrook Health Sciences Centre, one of Canada’s largest hospitals, offers a highly specialized comprehensive cancer program and treats more than 7,000 cancer patients per year. The center is equipped with 13 linear accelerators. This is the first sale made in Ontario since a Master Purchase Agreement was signed with Ontario Health in the first quarter of 2022.

The agreement includes a complete configuration of RayStation to fully replace the hospital’s existing treatment planning systems. The total order value is approximately CAD 6.2 million (approximately SEK 51.1 million), whereof at least CAD 3.5 million (SEK 28.8 million) is expected to constitute revenue in the third quarter of 2022. This excludes post-warranty support services which will amount to an additional CAD 1.88 million (approximately SEK 15.4 million) over the next eight years. A 36-month warranty is included in the order.

Johan Löf, founder and CEO, RaySearch, said: “Canada has one of the world’s most advanced cancer care programs. RaySearch has many strong relationships with Canadian centers, both clinical and academic, and we are proud to see that also Sunnybrook has put their trust in us and our innovative software. We look forward to working with this large and well-known center to further advance cancer treatment.”

For more information: www.raysearchlabs.com


Related Content

News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | FDA

Dec. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced ...

Time December 04, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
Subscribe Now